Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.57 |
| ▸ | CES1 | P23141 | 8/20 | 0.57 |
| ▸ | CES2 | O00748 | 5/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7159921 | 1.00 | FAAH (0.57) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL15349397 | 0.84 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL28521159 | 0.81 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL28466021 | 0.81 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL4748368 | 0.81 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL28458400 | 0.81 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL3778978 | 0.80 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL9435633 | 0.80 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL3787603 | 0.80 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL3777162 | 0.80 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0957107-B1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS LTD (JP) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003049672-A2 | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-06-19 | — | — | WO | disclosed |
| US-6541461-B2 | Treating viral infection; obtain mamal, administer vircide, monitor response to viricide | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020077472-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2002-06-20 | — | — | US | disclosed |
| US-6337390-B1 | MONOSACCHARIDE LIPID LINKED TO ANOMERIC CARBON OF SIALIC ACID OR KDN | NISSAN FOOD PRODUCTS CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| EP-0957107-A1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 1999-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077472-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | FAAH 2391/4885CES1 322/4885CES2 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.